Operating Company Healthcare

NeuroFlow

Philadelphia, Pennsylvania, United States

NeuroFlow helps risk-bearing healthcare organizations improve outcomes and cost of care in complex populations by surfacing and supporting behavioral health needs that typically go undetected and under-addressed. Across payors, providers, and the federal government, its scalable technology and analytics enable actionable intelligence from real-time data collection, risk stratification, and measurement-based care.

Focus Areas
Behavioral health technology, Behavioral health analytics, Risk stratification
Website
neuroflow.com

Tracked deals

3

3 tracked deals across 2024-2025.

Recent pace

0

0 tracked deals announced in the last 12 months.

Deal mix

Addon

1 addon · 1 buyout · 1 divestiture

NeuroFlow Acquisition Volume by Year

Last 2 years

Acquisition volume by year Annual acquisition counts for the last 2 years for NeuroFlow. 1 2024 2 2025

Supporting Data

Recent Transactions

  • Buyer
    NeuroFlow, Concord Health Partners
    Target
    Quartet Health, innovaTel (division of Quartet Health)
    Seller
    Quartet Health
    Type
    Addon

    NeuroFlow, a behavioral health technology and analytics company, has acquired Quartet Health to expand its provider network, referral management capabilities and AI-powered behavioral health platform. The deal (expected to close end of January 2025) will broaden NeuroFlow's offerings to payers, health systems and federal customers and follows related transactions by Concord Health Partners' portfolio (Iris Telehealth acquired Quartet's innovaTel division).

  • Buyer
    NeuroFlow
    Target
    Intermountain Health
    Seller
    Intermountain Health
    Industry
    Data & Analytics

    NeuroFlow has acquired Intermountain Health’s proprietary behavioral health analytics model and will integrate the clinically validated complexity model into its analytics and AI platform. The move expands NeuroFlow’s behavioral health risk-stratification capabilities for health systems, payors and other customers and enables national deployment of Intermountain’s evidence-based clinical workflows to improve whole-person care.

  • June 23, 2024
    Buyer
    NeuroFlow
    Target
    Owl
    Type
    Buyout

    NeuroFlow, a Philadelphia-based behavioral health technology provider, has acquired Owl, a measurement-based care company, to create an expanded end-to-end behavioral health measurement and engagement platform. The deal extends NeuroFlow's capabilities into outpatient behavioral health provider organizations and combines both firms' assessment, analytics and AI capabilities to support payers, providers and government customers across all 50 states.

Related Acquisition Pages

Selling a company? Get in front of buyers like NeuroFlow

Turn tracked acquisition activity into an outreach-ready buyer list.